Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
The chairs for AACR on Campus in Malaysia share how early-career researchers can benefit from the programs in Kuala...
During his Pezcoller Foundation-AACR Award lecture, Douglas Hanahan, PhD, FAACR, highlighted ways to overcome systemic immunosuppression.
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and...
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
A study suggests that modifying a patient’s gut microbiome could make their cancer more likely to respond to CAR...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...